| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 12 | 2023 | 380 | 0.990 |
Why?
|
| Adenocarcinoma | 25 | 2022 | 6310 | 0.950 |
Why?
|
| Microsatellite Repeats | 17 | 2005 | 786 | 0.920 |
Why?
|
| DNA Mismatch Repair | 6 | 2022 | 429 | 0.830 |
Why?
|
| Genes, APC | 11 | 2008 | 145 | 0.770 |
Why?
|
| Barrett Esophagus | 3 | 2021 | 490 | 0.750 |
Why?
|
| Appendiceal Neoplasms | 1 | 2023 | 155 | 0.750 |
Why?
|
| Colorectal Neoplasms | 29 | 2022 | 6855 | 0.740 |
Why?
|
| Colonic Neoplasms | 13 | 2016 | 2526 | 0.720 |
Why?
|
| Esophageal Neoplasms | 6 | 2021 | 1651 | 0.610 |
Why?
|
| Base Pair Mismatch | 10 | 2004 | 92 | 0.590 |
Why?
|
| Endometrial Neoplasms | 4 | 2023 | 1361 | 0.560 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2021 | 2927 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 23 | 2009 | 5333 | 0.470 |
Why?
|
| Keratins | 3 | 2021 | 497 | 0.470 |
Why?
|
| Jews | 6 | 2003 | 364 | 0.470 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2012 | 487 | 0.450 |
Why?
|
| Adenomatous Polyposis Coli | 6 | 2008 | 218 | 0.440 |
Why?
|
| Microsatellite Instability | 6 | 2016 | 715 | 0.430 |
Why?
|
| Cytoskeletal Proteins | 8 | 2005 | 1344 | 0.380 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2009 | 84 | 0.380 |
Why?
|
| Loss of Heterozygosity | 5 | 2011 | 659 | 0.330 |
Why?
|
| Dacarbazine | 2 | 2009 | 560 | 0.320 |
Why?
|
| Point Mutation | 4 | 1999 | 1594 | 0.310 |
Why?
|
| Adenoma | 12 | 2015 | 2148 | 0.310 |
Why?
|
| Genes, p53 | 9 | 2007 | 714 | 0.290 |
Why?
|
| Precancerous Conditions | 5 | 2018 | 978 | 0.290 |
Why?
|
| Neuroendocrine Tumors | 3 | 2009 | 649 | 0.280 |
Why?
|
| Genes, ras | 8 | 2007 | 654 | 0.280 |
Why?
|
| DNA, Neoplasm | 15 | 2007 | 1745 | 0.270 |
Why?
|
| Gastritis | 2 | 2023 | 198 | 0.260 |
Why?
|
| Germ-Line Mutation | 10 | 2009 | 1843 | 0.250 |
Why?
|
| MutS Homolog 2 Protein | 15 | 2015 | 195 | 0.250 |
Why?
|
| Neoplasm Proteins | 11 | 2008 | 3613 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2010 | 2823 | 0.250 |
Why?
|
| Colonic Polyps | 4 | 2022 | 550 | 0.250 |
Why?
|
| DNA Repair | 13 | 2004 | 2039 | 0.240 |
Why?
|
| Immunohistochemistry | 19 | 2021 | 11064 | 0.240 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2006 | 727 | 0.230 |
Why?
|
| Helicobacter heilmannii | 1 | 2023 | 6 | 0.230 |
Why?
|
| DNA-Binding Proteins | 14 | 2015 | 9590 | 0.230 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 951 | 0.230 |
Why?
|
| Intestinal Neoplasms | 5 | 2008 | 311 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 12 | 2005 | 4494 | 0.220 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2023 | 149 | 0.200 |
Why?
|
| Colitis | 3 | 2023 | 1229 | 0.200 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2009 | 321 | 0.200 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2006 | 698 | 0.190 |
Why?
|
| Trans-Activators | 5 | 2005 | 2861 | 0.180 |
Why?
|
| Adenomatous Polyps | 3 | 2008 | 108 | 0.180 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 377 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2805 | 0.180 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 386 | 0.180 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 243 | 0.170 |
Why?
|
| Genetic Techniques | 1 | 2003 | 428 | 0.170 |
Why?
|
| Esophagectomy | 2 | 2021 | 469 | 0.160 |
Why?
|
| Sulfonamides | 5 | 2009 | 1973 | 0.150 |
Why?
|
| Aneuploidy | 2 | 2001 | 551 | 0.150 |
Why?
|
| Pyrazoles | 5 | 2009 | 1992 | 0.150 |
Why?
|
| Adenomyoma | 1 | 1997 | 8 | 0.150 |
Why?
|
| beta Catenin | 7 | 2010 | 1043 | 0.150 |
Why?
|
| Gene Deletion | 8 | 2006 | 2668 | 0.140 |
Why?
|
| Common Bile Duct | 1 | 1997 | 106 | 0.140 |
Why?
|
| Thymidylate Synthase | 1 | 2016 | 72 | 0.140 |
Why?
|
| Gastrectomy | 1 | 2021 | 677 | 0.140 |
Why?
|
| Polymorphism, Genetic | 4 | 2008 | 4286 | 0.140 |
Why?
|
| Mutation | 24 | 2018 | 29950 | 0.140 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1997 | 118 | 0.140 |
Why?
|
| Cholecystitis | 1 | 1997 | 181 | 0.140 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 58947 | 0.130 |
Why?
|
| Muir-Torre Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
| Alleles | 8 | 2008 | 6900 | 0.130 |
Why?
|
| Bile Duct Diseases | 1 | 1996 | 97 | 0.130 |
Why?
|
| Adenomatous Polyposis Coli Protein | 5 | 2006 | 180 | 0.130 |
Why?
|
| Humans | 96 | 2023 | 760261 | 0.130 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2006 | 84 | 0.120 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1996 | 133 | 0.120 |
Why?
|
| Female | 66 | 2023 | 391011 | 0.120 |
Why?
|
| Lymph Nodes | 2 | 2006 | 3491 | 0.120 |
Why?
|
| Pancreatic Diseases | 1 | 1997 | 343 | 0.120 |
Why?
|
| Middle Aged | 51 | 2021 | 220175 | 0.120 |
Why?
|
| DNA Polymerase I | 1 | 1994 | 43 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1737 | 0.120 |
Why?
|
| Prognosis | 12 | 2021 | 29636 | 0.120 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2009 | 619 | 0.120 |
Why?
|
| Fluorouracil | 3 | 2016 | 1630 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 9 | 2011 | 6067 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 12 | 2015 | 2895 | 0.110 |
Why?
|
| Aged | 41 | 2021 | 168995 | 0.110 |
Why?
|
| BRCA1 Protein | 3 | 2000 | 1146 | 0.110 |
Why?
|
| Disease Progression | 8 | 2021 | 13505 | 0.110 |
Why?
|
| Carcinoma in Situ | 3 | 2005 | 796 | 0.110 |
Why?
|
| Endosonography | 1 | 1997 | 604 | 0.110 |
Why?
|
| Male | 59 | 2023 | 359413 | 0.110 |
Why?
|
| Vasculitis | 1 | 1997 | 523 | 0.110 |
Why?
|
| Carcinoma | 4 | 2015 | 2334 | 0.100 |
Why?
|
| DNA Mutational Analysis | 9 | 2008 | 4109 | 0.100 |
Why?
|
| Adult | 42 | 2021 | 219847 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2009 | 1720 | 0.100 |
Why?
|
| Enterocytes | 4 | 2007 | 220 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2021 | 3531 | 0.100 |
Why?
|
| DNA Repair Enzymes | 2 | 2015 | 345 | 0.100 |
Why?
|
| Intestinal Mucosa | 8 | 2008 | 3023 | 0.100 |
Why?
|
| Survival Analysis | 8 | 2009 | 10185 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2011 | 246 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1168 | 0.090 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 1919 | 0.090 |
Why?
|
| Cysts | 1 | 1996 | 683 | 0.090 |
Why?
|
| Neoplasm Staging | 7 | 2016 | 11141 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2811 | 0.090 |
Why?
|
| Codon | 3 | 1999 | 602 | 0.090 |
Why?
|
| Isoenzymes | 3 | 2004 | 1690 | 0.090 |
Why?
|
| Mutation, Missense | 3 | 2008 | 2563 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2009 | 517 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2008 | 277 | 0.090 |
Why?
|
| Bacitracin | 1 | 1989 | 24 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2007 | 4717 | 0.080 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2010 | 125 | 0.080 |
Why?
|
| Carrier Proteins | 11 | 2005 | 4938 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2010 | 2415 | 0.080 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2001 | 190 | 0.080 |
Why?
|
| Captopril | 1 | 1989 | 266 | 0.080 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 3 | 2004 | 318 | 0.080 |
Why?
|
| Nuclear Proteins | 11 | 2015 | 5793 | 0.080 |
Why?
|
| Pilomatrixoma | 2 | 2005 | 24 | 0.080 |
Why?
|
| HMGA1a Protein | 1 | 2008 | 61 | 0.080 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2008 | 40 | 0.080 |
Why?
|
| Pancreatic Ducts | 2 | 2008 | 329 | 0.080 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 128 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11708 | 0.080 |
Why?
|
| Leucine | 1 | 1989 | 548 | 0.070 |
Why?
|
| Cardia | 1 | 2007 | 59 | 0.070 |
Why?
|
| Hair Diseases | 2 | 2005 | 72 | 0.070 |
Why?
|
| Prevalence | 2 | 2022 | 15687 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3774 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2016 | 8498 | 0.070 |
Why?
|
| Liver Diseases | 1 | 1996 | 1301 | 0.070 |
Why?
|
| Carcinoid Tumor | 1 | 2009 | 228 | 0.070 |
Why?
|
| Leucovorin | 1 | 2009 | 639 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 729 | 0.070 |
Why?
|
| Keratin-20 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Keratin-7 | 1 | 2006 | 55 | 0.070 |
Why?
|
| Disease-Free Survival | 3 | 2016 | 6830 | 0.070 |
Why?
|
| Intestinal Polyps | 2 | 2008 | 104 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2007 | 168 | 0.070 |
Why?
|
| Risk Assessment | 6 | 2021 | 24086 | 0.070 |
Why?
|
| Heterozygote | 5 | 2003 | 2797 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2000 | 586 | 0.060 |
Why?
|
| Esophagogastric Junction | 1 | 2007 | 341 | 0.060 |
Why?
|
| Actomyosin | 1 | 2006 | 109 | 0.060 |
Why?
|
| Coumestrol | 1 | 2004 | 1 | 0.060 |
Why?
|
| Camptothecin | 1 | 2009 | 590 | 0.060 |
Why?
|
| Liver Neoplasms | 3 | 2008 | 4317 | 0.060 |
Why?
|
| Skin Neoplasms | 5 | 2009 | 5797 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 67 | 0.060 |
Why?
|
| Genistein | 1 | 2004 | 86 | 0.060 |
Why?
|
| Fungal Proteins | 3 | 2005 | 911 | 0.060 |
Why?
|
| Phytoestrogens | 1 | 2004 | 59 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2006 | 235 | 0.060 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2006 | 336 | 0.060 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2008 | 364 | 0.060 |
Why?
|
| Cadherins | 2 | 2006 | 898 | 0.060 |
Why?
|
| Intestinal Polyposis | 1 | 2004 | 42 | 0.060 |
Why?
|
| DNA Glycosylases | 1 | 2004 | 124 | 0.060 |
Why?
|
| Mice | 22 | 2023 | 81216 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2004 | 177 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2007 | 1705 | 0.060 |
Why?
|
| Bloom Syndrome | 1 | 2003 | 10 | 0.060 |
Why?
|
| Allelic Imbalance | 1 | 2004 | 77 | 0.060 |
Why?
|
| Mice, Nude | 5 | 2008 | 3605 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 785 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 11 | 2023 | 22025 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 1997 | 3526 | 0.050 |
Why?
|
| Pedigree | 9 | 2003 | 4577 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 580 | 0.050 |
Why?
|
| Breast Neoplasms | 7 | 2009 | 21065 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 18134 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2008 | 2052 | 0.050 |
Why?
|
| Phosphorylation | 5 | 2010 | 8314 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2001 | 1094 | 0.050 |
Why?
|
| Sigmoid Neoplasms | 2 | 2004 | 54 | 0.050 |
Why?
|
| Animals | 25 | 2023 | 167940 | 0.050 |
Why?
|
| Biopsy | 5 | 2018 | 6775 | 0.050 |
Why?
|
| Gastrointestinal Transit | 1 | 2002 | 99 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2005 | 704 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2000 | 12100 | 0.050 |
Why?
|
| Pouchitis | 1 | 2001 | 64 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2006 | 2945 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15273 | 0.050 |
Why?
|
| Nausea | 1 | 2023 | 677 | 0.050 |
Why?
|
| New England | 1 | 2023 | 1045 | 0.050 |
Why?
|
| Gastroenterology | 1 | 2007 | 571 | 0.040 |
Why?
|
| Genes, DCC | 1 | 1999 | 10 | 0.040 |
Why?
|
| Glucagon | 1 | 2002 | 532 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 1115 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 2000 | 115 | 0.040 |
Why?
|
| Ontario | 3 | 2008 | 405 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 640 | 0.040 |
Why?
|
| Molecular Sequence Data | 7 | 2000 | 17628 | 0.040 |
Why?
|
| Base Sequence | 6 | 1996 | 12447 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2255 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2005 | 559 | 0.040 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 1999 | 59 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 509 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2004 | 1172 | 0.040 |
Why?
|
| DNA, Satellite | 2 | 1996 | 67 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2008 | 2866 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2004 | 17766 | 0.040 |
Why?
|
| Hyperplasia | 4 | 2008 | 1158 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2005 | 1602 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2874 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2004 | 419 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2007 | 1304 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2005 | 1511 | 0.040 |
Why?
|
| Proteome | 1 | 2008 | 1856 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1135 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2001 | 867 | 0.040 |
Why?
|
| Frozen Sections | 1 | 1998 | 153 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2023 | 80301 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1655 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1174 | 0.040 |
Why?
|
| Neoplasms | 2 | 2004 | 22066 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2003 | 6131 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1998 | 385 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1064 | 0.040 |
Why?
|
| Cyclins | 2 | 1998 | 593 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1999 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 5230 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 3 | 2004 | 600 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1956 | 0.030 |
Why?
|
| Cell Movement | 2 | 2008 | 5206 | 0.030 |
Why?
|
| Exons | 2 | 2000 | 2391 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2004 | 3483 | 0.030 |
Why?
|
| Tyrosine | 3 | 2005 | 1440 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2018 | 391 | 0.030 |
Why?
|
| BRCA2 Protein | 2 | 2000 | 797 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2000 | 769 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2007 | 9388 | 0.030 |
Why?
|
| Intestines | 1 | 2004 | 1907 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2005 | 1423 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2010 | 534 | 0.030 |
Why?
|
| Genetic Markers | 4 | 2007 | 2608 | 0.030 |
Why?
|
| Vanadates | 2 | 2005 | 82 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64947 | 0.030 |
Why?
|
| Europe | 2 | 2000 | 3433 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 4357 | 0.030 |
Why?
|
| Intestine, Small | 3 | 2006 | 1207 | 0.030 |
Why?
|
| Breast Diseases | 1 | 1998 | 443 | 0.030 |
Why?
|
| Risk Factors | 9 | 2021 | 74269 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8551 | 0.030 |
Why?
|
| Melanoma | 2 | 2006 | 5695 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1999 | 1955 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2008 | 2449 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1997 | 505 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1999 | 601 | 0.030 |
Why?
|
| Cholestasis | 1 | 1997 | 374 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2012 | 13629 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 2880 | 0.030 |
Why?
|
| Computational Biology | 2 | 2004 | 3504 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2804 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3601 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2001 | 938 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2008 | 3482 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2421 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 3 | 2008 | 3618 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3207 | 0.030 |
Why?
|
| Child | 6 | 2023 | 79758 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 1997 | 880 | 0.030 |
Why?
|
| Dinoprostone | 2 | 2006 | 599 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 10829 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2008 | 12762 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9196 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2004 | 877 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 839 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 4891 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 1633 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2018 | 22041 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 2006 | 2093 | 0.020 |
Why?
|
| Signal Transduction | 6 | 2008 | 23363 | 0.020 |
Why?
|
| Phenotype | 6 | 2008 | 16543 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2002 | 20484 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2004 | 311 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2006 | 2282 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 12968 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 833 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 1977 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2004 | 4024 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2852 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2009 | 54263 | 0.020 |
Why?
|
| Models, Genetic | 3 | 2007 | 3442 | 0.020 |
Why?
|
| Homozygote | 2 | 2006 | 1786 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2009 | 8984 | 0.020 |
Why?
|
| Probability | 2 | 2007 | 2476 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2007 | 11480 | 0.020 |
Why?
|
| Peptides | 1 | 2002 | 4358 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 7468 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5120 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 1989 | 95 | 0.020 |
Why?
|
| Acute Disease | 2 | 1997 | 7268 | 0.020 |
Why?
|
| DNA | 1 | 2003 | 7236 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 6030 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2006 | 3096 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1900 | 0.020 |
Why?
|
| Back | 1 | 2008 | 64 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13456 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2006 | 1760 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 9531 | 0.020 |
Why?
|
| Keratoacanthoma | 1 | 2008 | 33 | 0.020 |
Why?
|
| Digoxin | 1 | 1989 | 247 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 693 | 0.020 |
Why?
|
| Genotype | 3 | 2005 | 12959 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 319 | 0.020 |
Why?
|
| Genome | 2 | 2007 | 1739 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2009 | 9274 | 0.020 |
Why?
|
| Feces | 1 | 1994 | 1466 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1989 | 1314 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2008 | 6242 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 871 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1989 | 1388 | 0.020 |
Why?
|
| Time Factors | 3 | 2021 | 40133 | 0.020 |
Why?
|
| Mice, Knockout | 4 | 2006 | 14396 | 0.020 |
Why?
|
| Metaplasia | 1 | 2007 | 320 | 0.020 |
Why?
|
| Receptors, Prostaglandin | 1 | 2006 | 54 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 2006 | 72 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2006 | 63 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1539 | 0.020 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2006 | 42 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2006 | 169 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2006 | 43 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2006 | 4127 | 0.020 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2006 | 87 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 16905 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1998 | 358 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 13967 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2006 | 121 | 0.020 |
Why?
|
| Survival Rate | 3 | 2008 | 12806 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2006 | 48 | 0.020 |
Why?
|
| Colectomy | 2 | 2004 | 694 | 0.020 |
Why?
|
| Chromosome Mapping | 3 | 2000 | 4625 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 370 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15740 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 616 | 0.020 |
Why?
|
| Rosmarinus | 1 | 2005 | 1 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2006 | 124 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 642 | 0.020 |
Why?
|
| Muscle Relaxants, Central | 1 | 2006 | 92 | 0.020 |
Why?
|
| Thorax | 1 | 2008 | 553 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2008 | 814 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2004 | 48 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 69 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2007 | 657 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 697 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1997 | 5960 | 0.010 |
Why?
|
| Multivariate Analysis | 3 | 2004 | 12156 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1833 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2004 | 237 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1672 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2004 | 14656 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 2006 | 339 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2004 | 574 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 12532 | 0.010 |
Why?
|
| Sequence Deletion | 2 | 2000 | 1493 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2005 | 468 | 0.010 |
Why?
|
| Amides | 1 | 2006 | 448 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 301 | 0.010 |
Why?
|
| Clathrin | 1 | 2004 | 257 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2004 | 1143 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 453 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 736 | 0.010 |
Why?
|
| Extremities | 1 | 2008 | 867 | 0.010 |
Why?
|
| Proglucagon | 1 | 2002 | 32 | 0.010 |
Why?
|
| Remission Induction | 1 | 2008 | 2394 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 631 | 0.010 |
Why?
|
| Atrophy | 1 | 2007 | 1625 | 0.010 |
Why?
|
| Registries | 2 | 1997 | 8449 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2004 | 611 | 0.010 |
Why?
|
| Mohs Surgery | 1 | 2005 | 221 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 2004 | 576 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 58673 | 0.010 |
Why?
|
| Membrane Proteins | 3 | 2004 | 7854 | 0.010 |
Why?
|
| Abdomen | 1 | 2008 | 1124 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1997 | 1056 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 561 | 0.010 |
Why?
|
| Sex Factors | 1 | 1996 | 10530 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 749 | 0.010 |
Why?
|
| Sulindac | 1 | 2001 | 29 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2008 | 10434 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 2009 | 39254 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 349 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2004 | 553 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2001 | 98 | 0.010 |
Why?
|
| Syndrome | 1 | 2008 | 3278 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2596 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1993 | 0.010 |
Why?
|
| Glycine | 1 | 2004 | 663 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 516 | 0.010 |
Why?
|
| Chromosomes | 1 | 2004 | 575 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 1767 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 1649 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2006 | 1201 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 2192 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2009 | 1387 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 613 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1577 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6545 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2262 | 0.010 |
Why?
|
| Furans | 1 | 2001 | 199 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 751 | 0.010 |
Why?
|
| Adolescent | 5 | 2005 | 87747 | 0.010 |
Why?
|
| Estrogens | 1 | 2007 | 1520 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 3584 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2006 | 933 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1548 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 897 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2004 | 1218 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2002 | 366 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2846 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2004 | 840 | 0.010 |
Why?
|
| Models, Biological | 2 | 2007 | 9468 | 0.010 |
Why?
|
| Quinazolines | 1 | 2006 | 1363 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 20048 | 0.010 |
Why?
|
| Age Factors | 1 | 1996 | 18415 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2002 | 560 | 0.010 |
Why?
|
| Genetic Testing | 2 | 2005 | 3530 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 1790 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3847 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2006 | 1534 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3302 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1999 | 347 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2003 | 612 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1755 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4900 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 3105 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 706 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 1189 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 1739 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 3605 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4573 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1998 | 328 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2004 | 41317 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1792 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3804 | 0.010 |
Why?
|
| Family | 2 | 2000 | 3189 | 0.010 |
Why?
|
| Colostomy | 1 | 1997 | 105 | 0.010 |
Why?
|
| Introns | 1 | 1999 | 978 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2202 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 1802 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6499 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 899 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2909 | 0.010 |
Why?
|
| Morbidity | 1 | 2001 | 1765 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2441 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2931 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3683 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3665 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2007 | 2321 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 1258 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2004 | 2255 | 0.010 |
Why?
|
| Proteomics | 1 | 2008 | 3810 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2000 | 1075 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2000 | 2381 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4002 | 0.010 |
Why?
|
| Aspirin | 1 | 2006 | 3365 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 2877 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1995 | 446 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 36030 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 5201 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2000 | 608 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1997 | 581 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9336 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1989 | 8523 | 0.010 |
Why?
|
| Meiosis | 1 | 1995 | 327 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4091 | 0.010 |
Why?
|
| Pancreas | 1 | 2000 | 1677 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 42034 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 2104 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 1997 | 625 | 0.010 |
Why?
|
| Longevity | 1 | 2000 | 1050 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 5790 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 5726 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1994 | 534 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8487 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4875 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 2014 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2000 | 2837 | 0.010 |
Why?
|
| Oncogenes | 1 | 1997 | 1221 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7592 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 2413 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5873 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1994 | 671 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 15626 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 21378 | 0.010 |
Why?
|
| DNA Replication | 1 | 1997 | 1412 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1994 | 1387 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 5301 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 5507 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 3448 | 0.000 |
Why?
|
| Cholangiocarcinoma | 1 | 1994 | 547 | 0.000 |
Why?
|
| Health Education | 1 | 1995 | 1049 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1995 | 2378 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1994 | 1100 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2001 | 9283 | 0.000 |
Why?
|
| Colon | 1 | 1994 | 1788 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 8945 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3726 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1995 | 3598 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1995 | 8018 | 0.000 |
Why?
|